About Alberto Paz
Form D filings for TSP Therapeutics in 2024 list Alberto Paz as chief executive and director.
Alberto Paz first appears on SEC filings in 2024.
Experience
This experience comes from SEC filings. The years are when the filings name Alberto Paz in the role, so the role may have started earlier or lasted longer.